You are here
Chembio Diagnostics to Participate in the BTIG Medical Technology, Life Science and Diagnostic Tools Conference
MEDFORD, N.Y., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the Company plans to participate in the upcoming BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah. Chembio’s management will be participating in one-on-one meetings on Wednesday, February 27, 2019. Due to the format of this event no webcast is available.
Tuesday, February 19, 2019 - 18:17